A large-scale population genomic study has shed new light on the evolutionary and domestication history of the button ...

New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND meeting held in 4Q 2025 followin ...

PanMAN data structures compress pangenomes massively, encode evolutionary histories, and enable scalable analysis of millions of genomes.

"We believe we are at the start of a major expansion of what's possible for patients with cancer and genetic disease," said John Finn, Chief Scientific Officer at Basecamp Research. "By using AI to ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Engineers at the University of California have developed a new data structure and compression technique that enables the ...

The study’s authors include scientists from Colorado State University, the CSU Veterinary Diagnostic Laboratories and the ...

Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building upon its reputation for rigorous quality, custom ...

The AI model "Eden" is intended to generate new gene therapies for cancer and rare diseases, as well as active ingredients ...

Learn how researchers at the Institute of Cancer Research in London are hoping to find out what changes in diet, lifestyle, ...

Presented preclinical data supporting APOC3 as a new collaboration target with Ionis Pharmaceuticals (“Ionis”) at the Nature Conference, “Cracking the Code: Nucleic Acid Medicines Coming of Age” APOC3 ...

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...